ES2170193T3 - Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso. - Google Patents

Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.

Info

Publication number
ES2170193T3
ES2170193T3 ES96200623T ES96200623T ES2170193T3 ES 2170193 T3 ES2170193 T3 ES 2170193T3 ES 96200623 T ES96200623 T ES 96200623T ES 96200623 T ES96200623 T ES 96200623T ES 2170193 T3 ES2170193 T3 ES 2170193T3
Authority
ES
Spain
Prior art keywords
salt
sodium chloride
weight
granules
nacl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96200623T
Other languages
English (en)
Inventor
Leon Ninane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9477467&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2170193(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay SA filed Critical Solvay SA
Application granted granted Critical
Publication of ES2170193T3 publication Critical patent/ES2170193T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/26—Preventing the absorption of moisture or caking of the crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/22—Preparation in the form of granules, pieces, or other shaped products
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/22—Preparation in the form of granules, pieces, or other shaped products
    • C01D3/24—Influencing the crystallisation process

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

SAL QUE COMPRENDE MAS DE 99,0% EN PESO DE CLORURO DE SODIO, EN ESTADO DE GRANULOS ESFERICOS DE DIAMETRO MEDIO SUPERIOR A 0,6 MM E INFERIOR A 3 MM Y SU UTILIZACION COMO SAL FARMACEUTICA.
ES96200623T 1995-03-24 1996-03-07 Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso. Expired - Lifetime ES2170193T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503588A FR2732004B1 (fr) 1995-03-24 1995-03-24 Sel comprenant du chlorure de sodium et moins de 5% en poids d'eau et son utilisation

Publications (1)

Publication Number Publication Date
ES2170193T3 true ES2170193T3 (es) 2002-08-01

Family

ID=9477467

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96200623T Expired - Lifetime ES2170193T3 (es) 1995-03-24 1996-03-07 Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.

Country Status (11)

Country Link
EP (1) EP0733590B1 (es)
JP (1) JPH08259223A (es)
KR (1) KR100424000B1 (es)
AT (1) ATE211118T1 (es)
CA (1) CA2171174A1 (es)
DE (1) DE69618053T2 (es)
DK (1) DK0733590T3 (es)
ES (1) ES2170193T3 (es)
FR (1) FR2732004B1 (es)
NO (1) NO961189L (es)
PT (1) PT733590E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821344B1 (fr) * 2001-02-26 2003-04-25 Solvay Granule de substance minerale agglomeree, resistant a l'abrasion, poudre comprenant de tels granules et procede pour sa fabrication
WO2009087645A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research Free flowing 100 - 500 mm size spherical crystals of common salt and process for preparation thereof
CN107382380A (zh) * 2017-07-27 2017-11-24 蓝德环保科技集团股份有限公司 一种利用草木灰制备生物钾肥的方法
CN107522211B (zh) * 2017-08-18 2019-08-09 天津大学 一种球形氯化钾及其制备方法
CN111302362B (zh) * 2020-04-03 2021-05-07 天津科技大学 一种大颗粒球形盐及其制备方法
CN113999734A (zh) * 2021-10-26 2022-02-01 中盐工程技术研究院有限公司 一种提高软水效能的洗碗机专用盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562884B1 (fr) * 1984-04-16 1988-12-30 Solvay Procede pour la production de sel et sel obtenu par ce procede
JPH01145320A (ja) * 1987-11-30 1989-06-07 Japan Tobacco Inc ８〜１４面体結晶食塩製造方法
FR2634665B1 (fr) * 1988-07-29 1991-12-13 Solvay Procede et installation pour la cristallisation d'une substance minerale et cristaux de chlorure de sodium

Also Published As

Publication number Publication date
ATE211118T1 (de) 2002-01-15
EP0733590A1 (fr) 1996-09-25
NO961189L (no) 1996-09-25
EP0733590B1 (fr) 2001-12-19
PT733590E (pt) 2002-06-28
DK0733590T3 (da) 2002-04-15
CA2171174A1 (fr) 1996-09-25
FR2732004B1 (fr) 1997-05-30
DE69618053T2 (de) 2002-09-12
KR100424000B1 (ko) 2004-06-23
FR2732004A1 (fr) 1996-09-27
JPH08259223A (ja) 1996-10-08
DE69618053D1 (de) 2002-01-31
KR960034075A (ko) 1996-10-22
NO961189D0 (no) 1996-03-22

Similar Documents

Publication Publication Date Title
ITRM920489A1 (it) Procedimento per evitare le instabilita' del comportamento su strada di autoveicoli.
ES2099438T3 (es) Polvo seco y estable de cefalosporina hidratada para formulacion de suspension oral.
DE69318783D1 (de) Verwendung von (S)-(+)-Hydroxychloroquine
FR2678513B1 (fr) Pansement cicatrisant.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2167462T3 (es) Composiciones granulares.
ES2170193T3 (es) Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
NO945070D0 (no) Absorberende hydrogelpartikler i absorpsjonsstrukturer
IT9021502A0 (it) Miscela stabilizzante per composti ad attivita' fotocromatica
IT1232305B (it) Composizione deodorante in granuli sui quali e'adsorbito un profumo od un olio essenziale
YU49138B (sh) Proteinski derivat humane lipaze stimulisane žučnom soli
PL308357A1 (en) Derivatives of benzofurane as antagonistic substances in respect to 5-ht1 type receptors
KR880008808A (ko) 비경구투여용 현탁액
DK0406732T3 (da) Lavviskos, højkoncentreret suspension af overfladeaktivt stof
EP0129947A3 (en) Contraceptive compositions based on esters of levo-norgestrel
ATE181833T1 (de) Wasserdispergierbare tablette enthaltend lamotrigin
GB9107763D0 (en) Substituted furan sulfonamides as antiglaucoma agents
CO4480101A1 (es) Compuestos ariltios
ATE128866T1 (de) Verwendung von naproxen als mydriatikum.
RU97122231A (ru) Состав для регулирования разработки нефтяных месторождений
KR890023982U (ko) 모드 변화에 따른 모니터의 수직크기 조정회로
ITTO920910A0 (it) Aggancio elastico dell'appoggiatusta al sedile veicolare.
IT235749Y1 (it) Utilizzo di molle per realizzare ortesi dinamiche dell'arto inferioreal fine di ottenere il recupero funzionale della deambulazione dopo
IT8633192V0 (it) Dispositivo regolatore dell'elasticita' o flessione di listelli paralleli particolarmente per brande o reti cosiddette ortopediche da letto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 733590

Country of ref document: ES